BOLD Boundless Bio, Inc.
Healthcare$1.47+0.00%OpenMarket Cap: $32.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.37
P/S
0.00
EV/EBITDA
-1.11
DCF Value
$-1.46
FCF Yield
-147.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-53.6%
ROA
-39.7%
ROIC
-45.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-14.5M | $-13.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-14.0M | $-12.9M | $— | — |
| FY null | $0.00 | -Infinity% | $-63.6M | $-58.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-15.1M | $-13.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-17.1M | $-15.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-17.3M | $-15.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-18.3M | $-16.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-73.3M | $-65.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-18.7M | $-16.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-19.4M | $-17.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-16.9M | $-15.4M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-13.8M | $-12.1M | $-0.55 | — |